• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥密克戎BA.2主导时期医院员工中新型冠状病毒2的临床和分子特征

Clinical and molecular fingerprint of SARS-CoV-2 among hospital employees in a period of Omicron BA.2 dominance.

作者信息

Rauschning Dominic, Weppler Ruth, Balczun Carsten, Scheumann Gwendolyn, Marques Jasmin Monteiro, Mutschnik Christina, Preuß Dominic, Schmithausen Ricarda Maria, Starke Maximilian, Hagen Ralf Matthias, Döhla Manuel

机构信息

Bundeswehr Central Hospital Koblenz, Department I B: Internal Medicine, Koblenz, Germany.

University Hospital Cologne, Department I of Internal Medicine, Cologne, Germany.

出版信息

GMS Hyg Infect Control. 2025 Feb 24;20:Doc02. doi: 10.3205/dgkh000531. eCollection 2025.

DOI:10.3205/dgkh000531
PMID:40352653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12059803/
Abstract

In the spring of 2022, SARS-CoV-2 Omicron BA.2 peaked in Germany. The main burden was staff shortage. To achieve effective identification and management of infected persons as well as early reintegration of recovered persons, an infection-control outpatient clinic was established at the Bundeswehr Central Hospital Koblenz. This article reports a secondary data analysis of 663 people with 1,174 visits to the outpatient clinic. For asymptomatic contacts, no correlation was observed between PCR result and testing time or frequency. Although no significant symptoms were documented, a high correlation was found between a positive antigen self-test and positive PCR. For clearance, a median time until a negative test was obtained was 8-11 days. The PCR gold standard was compared with ECLIA antigen testing for all indications. The results of this study challenge the rationale for testing asymptomatic contacts. Solely symptom-driven diagnostics by PCR also do not seem to be effective. However, contact persons or symptomatic persons with a positive rapid antigen test should be tested further. Whether this testing is done by ECLIA or PCR does not seem to matter. Clearance testing after recovery prior to day 8 is also not appropriate.

摘要

2022年春季,严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)奥密克戎BA.2毒株在德国达到高峰。主要问题是人员短缺。为了有效识别和管理感染者以及使康复者早日重返工作岗位,科布伦茨联邦国防军中央医院设立了一家感染控制门诊。本文报告了对663人进行1174次门诊就诊的二次数据分析。对于无症状接触者,未观察到聚合酶链反应(PCR)结果与检测时间或频率之间的相关性。尽管未记录到明显症状,但抗原自我检测呈阳性与PCR检测呈阳性之间存在高度相关性。为了获得清除结果,获得阴性检测结果的中位时间为8至11天。针对所有适应症,将PCR金标准与电化学发光免疫分析(ECLIA)抗原检测进行了比较。本研究结果对无症状接触者检测的基本原理提出了挑战。仅通过PCR进行症状驱动的诊断似乎也无效。然而,快速抗原检测呈阳性的接触者或有症状者应进一步检测。检测是通过ECLIA还是PCR进行似乎并不重要。在第8天之前进行康复后的清除检测也不合适。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/12059803/58edee477123/HIC-20-02-g-002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/12059803/afb3ffe64e77/HIC-20-02-t-002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/12059803/e5b09885f104/HIC-20-02-t-004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/12059803/c3759bb7ce80/HIC-20-02-t-005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/12059803/6da56980175a/HIC-20-02-g-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/12059803/58edee477123/HIC-20-02-g-002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/12059803/afb3ffe64e77/HIC-20-02-t-002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/12059803/e5b09885f104/HIC-20-02-t-004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/12059803/c3759bb7ce80/HIC-20-02-t-005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/12059803/6da56980175a/HIC-20-02-g-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5335/12059803/58edee477123/HIC-20-02-g-002.jpg

相似文献

1
Clinical and molecular fingerprint of SARS-CoV-2 among hospital employees in a period of Omicron BA.2 dominance.奥密克戎BA.2主导时期医院员工中新型冠状病毒2的临床和分子特征
GMS Hyg Infect Control. 2025 Feb 24;20:Doc02. doi: 10.3205/dgkh000531. eCollection 2025.
2
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对 SARS-CoV-2 感染(COVID-RED)的远程早期检测的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Oct 11;22(1):694. doi: 10.1186/s13063-021-05643-5.
3
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对远程早期检测 SARS-CoV-2 感染(COVID-RED)的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jun 22;22(1):412. doi: 10.1186/s13063-021-05241-5.
4
COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods.在德尔塔和奥密克戎 BA.1 变异株流行期间社区检测和监测点的 COVID-19 症状和快速抗原检测阳性持续时间。
JAMA Netw Open. 2022 Oct 3;5(10):e2235844. doi: 10.1001/jamanetworkopen.2022.35844.
5
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原和基于分子的检测。
Cochrane Database Syst Rev. 2021 Mar 24;3(3):CD013705. doi: 10.1002/14651858.CD013705.pub2.
6
Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA.4/5, and XBB dominance in Hong Kong: a prospective cohort study.香港奥密克戎BA.2、BA.4/5和XBB主导期间SARS-CoV-2社区感染的临床特征分析:一项前瞻性队列研究
Lancet Infect Dis. 2025 Mar;25(3):276-289. doi: 10.1016/S1473-3099(24)00574-7. Epub 2024 Oct 14.
7
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
8
SARS-CoV-2 rapid antigen test sensitivity and viral load in newly symptomatic hospital employees in Berlin, Germany, December, 2020 to February, 2022: an observational study.2020 年 12 月至 2022 年 2 月期间德国柏林新出现症状的住院员工中 SARS-CoV-2 快速抗原检测的敏感性和病毒载量:一项观察性研究。
Lancet Microbe. 2024 Jun;5(6):e538-e546. doi: 10.1016/S2666-5247(23)00412-3. Epub 2024 May 14.
9
Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2 : A Secondary Analysis From a Serial Home Self-testing Study.德尔塔和奥密克戎变异株 SARS-CoV-2 的快速抗原检测性能比较:一项连续家庭自测研究的二次分析。
Ann Intern Med. 2022 Dec;175(12):1685-1692. doi: 10.7326/M22-0760. Epub 2022 Oct 11.
10
Diagnostic performance of rapid antigen tests (RAT) for COVID-19 and factors associated with RAT-negative results among RT-PCR-positive individuals during Omicron BA.2, BA.5 and XBB.1 predominance.奥密克戎 BA.2、BA.5 和 XBB.1 流行期间,针对 COVID-19 的快速抗原检测(RAT)的诊断性能以及与 RT-PCR 阳性个体中 RAT 阴性结果相关的因素。
BMC Infect Dis. 2024 May 21;24(1):504. doi: 10.1186/s12879-024-09408-8.

本文引用的文献

1
COVID-19 and isolation: Risks and implications in the scenario of new variants.新型变种下的 COVID-19 与隔离:风险与影响。
Braz J Infect Dis. 2022 Sep-Oct;26(5):102703. doi: 10.1016/j.bjid.2022.102703. Epub 2022 Sep 6.
2
Daily testing of contacts of SARS-CoV-2 infected cases as an alternative to quarantine for key workers in Liverpool: A prospective cohort study.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染病例的密切接触者进行每日检测,作为利物浦关键工作人员隔离替代措施的前瞻性队列研究。
EClinicalMedicine. 2022 Jul 1;50:101519. doi: 10.1016/j.eclinm.2022.101519. eCollection 2022 Aug.
3
Evaluation of Diagnostic Strategies for Identifying SARS-CoV-2 Infection in Clinical Practice: a Systematic Review and Compliance with the Standards for Reporting Diagnostic Accuracy Studies Guideline (STARD).
评估临床实践中识别 SARS-CoV-2 感染的诊断策略:系统评价及对诊断准确性研究报告标准(STARD)的遵循情况。
Microbiol Spectr. 2022 Aug 31;10(4):e0030022. doi: 10.1128/spectrum.00300-22. Epub 2022 Jun 14.
4
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.无症状和出现症状前 SARS-CoV-2 感染的发生和传播潜力:实时系统评价和荟萃分析更新。
PLoS Med. 2022 May 26;19(5):e1003987. doi: 10.1371/journal.pmed.1003987. eCollection 2022 May.
5
Duration of COVID-19 PCR positivity for Omicron vs earlier variants.奥密克戎毒株与早期变体的新冠病毒聚合酶链式反应阳性持续时间。
J Clin Virol Plus. 2022 Aug;2(3):100085. doi: 10.1016/j.jcvp.2022.100085. Epub 2022 May 21.
6
Time from Exposure to Diagnosis among Quarantined Close Contacts of SARS-CoV-2 Omicron Variant Index Case-Patients, South Korea.韩国 SARS-CoV-2 奥密克戎变异株确诊病例密切接触者隔离期间的发病时间。
Emerg Infect Dis. 2022 Apr;28(4):901-903. doi: 10.3201/eid2804.220153.
7
Diagnostic performance of the fully automated Roche Elecsys SARS-CoV-2 antigen electrochemiluminescence immunoassay: a pooled analysis.罗氏 Elecsys SARS-CoV-2 抗原电化学发光免疫分析全自动检测的诊断性能:汇总分析。
Clin Chem Lab Med. 2022 Feb 3;60(5):655-661. doi: 10.1515/cclm-2022-0053. Print 2022 Apr 26.
8
Molecular accuracy vs antigenic speed: SARS-CoV-2 testing strategies.分子精度与抗原速度:SARS-CoV-2 检测策略。
Curr Opin Pharmacol. 2022 Feb;62:152-158. doi: 10.1016/j.coph.2021.12.006. Epub 2021 Dec 21.
9
Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster - Nebraska, November-December 2021.调查 SARS-CoV-2 B.1.1.529(奥密克戎)变异株集群——内布拉斯加州,2021 年 11 月至 12 月。
MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1782-1784. doi: 10.15585/mmwr.mm705152e3.
10
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021.2021 年 11 月至 12 月,在挪威发生的由 SARS-CoV-2 奥密克戎变异株引起的疫情。
Euro Surveill. 2021 Dec;26(50). doi: 10.2807/1560-7917.ES.2021.26.50.2101147.